[Cancer of the oropharynx and oral cavity : results of low dose telecobalt irradiation (author's transl)].
A study has been conducted from August 1977 to compare the results of conventional fractionated irradiation (CFI) and low dose irradiation (LDI) in cancer of the oropharynx and oral cavity. Skin tolerance was perfect and mucusal tolerance satisfactory after LDI whatever the dose, and tumoral and lymph node regression and the 1-year survival rate comparable with those obtained after CFI. A dose of 1.5 Gy/h is suggested for future application, oropharyngeal tumors responding best to this type of irradiation.
D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000000981:diagnostic imaging*; D009960:Oropharynx; D010610:Pharyngeal Neoplasms / Q000532:radiotherapy*; D011859:Radiography; D011867:Radioisotope Teletherapy / Q000379:methods*; D011879:Radiotherapy Dosage
D003037:Cobalt Radioisotopes
Bilan de l'irradiation à faible débit par télécobalt dans les cancers de l'oropharynx et de la cavité buccale.